"Development of WARS1-targeted autoimmune disease therapy," MirimGENE launch pre-clinical

Date : 2023.08.17    Hit : 106

CEO Jin Mirim conducted an interview with HitNews on the topic of “MirimGENE's core pipeline status and future blueprint.” 
 
View Source :  http://www.hitnews.co.kr/news/articleView.html?idxno=47468 


Source : HItNews , 17.Aug.2023.
 

• Prev 22nd Women’s Bioscience Forum Symposium Presentation
• Next Enzaim Healthcare IR communication seminar